Source link : https://newshealth.biz/health-news/integrating-car-t-and-bispecific-antibodies-in-mm-treatment/
MILAN — The treatment landscape for relapsed and refractory multiple myeloma (RRMM) has shifted dramatically with the emergence of immunotherapies such as chimeric antigen receptor (CAR) T-cell therapies and bispecific antibodies (bsAbs). These novel approaches have delivered unprecedented outcomes in heavily pretreated patients. Yet determining the optimal treatment strategy remains a clinical challenge. Here at […]
The post Integrating CAR T and Bispecific Antibodies in MM Treatment first appeared on News Health.
—-
Author : News Health
Publish date : 2025-06-17 17:50:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8